Janssen - Advanced prostate cancer: How do we move forward in patient management?
Non metastatic castration resistant prostate cancer translating benefit to clinical practice & Choosing the right pathway in the current and future management of metastatic castration resistant prostate cancer
Date
14 Sep 2020Session
Janssen - Advanced prostate cancer: How do we move forward in patient management?Presenters
Nicolas MottetAuthors
B.A. Hadaschik1, K.N. Chi2, E. Efstathiou3, N. Mottet4Author affiliations
- 1 Department Of Urology, University Hospital of Essen, 45147 - Essen/DE
- 2 Medical Oncology Department, BC Cancer Agency - Vancouver, V5Z 4E6 - Vancouver/CA
- 3 The M. D. Anderson Cancer Center, 77030 - Houston/US
- 4 Uro-oncology Department, CHU Saint Etienne - Hopital Nord, 42055 - Saint-Étienne/FR
Resources
Resources from the same session
Optimising care for individual patients with metastatic hormone sensitive prostate cancer
Presenter: Nicolas Mottet
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast
Flattening the curve: Consequences for the management of prostate cancer in the ongoing COVID-19 pandemic
Presenter: Boris Hadaschik
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast
Live Q&A - 18 September 2020 - 17:00-18:00
Presenter: Boris Hadaschik
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast